Description
Retatrutide 30MG
Retatrutide is an investigational triple receptor agonist designed to activate the GIP, GLP-1, and glucagon receptors within a single molecule. Research has examined this combined receptor activity in relation to metabolic signaling, glucose homeostasis, energy regulation, appetite-related pathways, and body-weight-associated biological mechanisms.
Product Details
Product: Retatrutide
Strength: 30MG
Volume: 03ML
SKU: SP133
Price: $415
Category: Metabolic Weight Optimization
Use: Research Use Only
About Retatrutide
Retatrutide is distinguished by its activity across three metabolic hormone receptor systems. Experimental and clinical research has explored how combined GIP, GLP-1, and glucagon receptor signaling may influence metabolic processes, energy expenditure, glucose-associated mechanisms, and appetite-related signaling.
Research Areas of Interest
GIP receptor signaling
GLP-1 receptor signaling
Glucagon receptor signaling
Metabolic regulation
Energy-balance pathways
Glucose-related signaling
Insulin-related pathways
Appetite and satiety research
Body-weight regulation research
Multi-receptor agonist research
Research Use Statement
Retatrutide 30MG is intended strictly for laboratory, analytical, and research purposes only. It is not for human or animal consumption and is not intended for medical, diagnostic, or therapeutic use.
Reviews
There are no reviews yet.